Home Molecular Dx Liquid Biopsies

Liquid Biopsies

Latest
Inivata and Thermo Fisher Scientific are collaborating with Genomics England to assess the quality of blood plasma samples and explore the potential of liquid biopsy to improve disease management and patient outcomes. [Source: © Alex Tihonov/Fotolia]
Liquid Biopsies

Resolution Bioscience, Mirati Therapeutics Ink CDx Deal

The combination of Bristol-Myers Squibb (BMS)'s marketed cancer immunotherapies Opdivo (nivolumab) plus a low dose of Yervoy (ipilimumab) showed durable clinical benefit in a Phase II trial as a first-line treatment in patients with microsatellite instability-high (MSI-H) or DNA mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC)
Liquid Biopsies

Guardant Throws Hat in Early Cancer Detection Ring with CRC Test

brain tumor
Liquid Biopsies

Cerebrospinal Fluid Samples Provide Accurate Picture of Medulloblastoma

Liquid Biopsies

Exact Sciences Eyes Cancer Dx Leadership with Up to $2.5B in...

Glioma - brain tumor
Liquid Biopsies

Glioma Diagnosis, Monitoring Potentially Improved by Enhanced Liquid Biopsy Test

Faecali bacterium
Liquid Biopsies

Prime Time for the Microbiome

ersonal Genome Diagnostics (PGDx) said today that its 500+ gene pan-cancer tumor profiling tissue assay is being used by Merck & Co. in a Phase II clinical trial designed to assess patient response to a dual biomarker-directed precision oncology combination therapy in patients with previously untreated advanced non-small cell lung cancer (NSCLC).
Liquid Biopsies

Biocept’s NSCLC Liquid Biopsy Gains Coverage from Insurer Highmark

Liquid Biopsies

Freenome Raises $270M in Series C Financing for Cancer Tests Based...

Liquid Biopsies

FDA Approves First NGS-Based Liquid Biopsy Companion Diagnostic

|Epic Science’s lab
Liquid Biopsies

It’s in the Blood

Load more

New Products

View More
Load more
Copyright © 2020 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up